SCHEMBL5752435

SCHEMBL5752435

COc1ccc(OC)c(CNc2ccnc(Cl)n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 15/20 0.56
CYP3A4 P08684 15/20 0.56
CYP2C19 P33261 14/20 0.56
CYP2D6 P10635 13/20 0.56
TSHR P16473 13/20 0.56
LMNA P02545 6/20 0.56
CLK4 Q9HAZ1 6/20 0.56
ALDH1A1 P00352 4/20 0.56
GLA P06280 2/20 0.56
USP2 O75604 10/20 0.54
ALOX15 P16050 6/20 0.54
CYP2C9 P11712 4/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPK1 P28482 3/20 0.54
HSD17B10 Q99714 5/20 0.52
MAPT P10636 2/20 0.51
CASP7 P55210 1/20 0.51
GAA P10253 1/20 0.49
DHFR P00374 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4861102 1.00 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C19CYP2D6TSHR
SCHEMBL3452299 0.90 CYP1A2 (0.69) CYP1A2CYP3A4CYP2C19CYP2D6TSHR
SCHEMBL4823978 0.83 CYP1A2 (0.70) CYP1A2CYP3A4CYP2C19CYP2D6TSHR
SCHEMBL27661951 0.80 CYP1A2 (0.54) CYP1A2CYP3A4CYP2C19CYP2D6TSHR
SCHEMBL13504222 0.80 CLK4 (0.68) CYP1A2CYP3A4CYP2C19CYP2D6TSHR
SCHEMBL14486766 0.80 CYP3A4 (0.51) CYP1A2CYP3A4CYP2C19CYP2D6TSHR
SCHEMBL28114877 0.78 CLK4 (0.61) CYP1A2CYP3A4CYP2C19CYP2D6TSHR
SCHEMBL4820325 0.75 GAA (0.62) LMNAALDH1A1USP2MEN1KMT2A
SCHEMBL15465606 0.74 CYP1A2 (0.69) CYP1A2CYP3A4CYP2C19CYP2D6TSHR
SCHEMBL3451889 0.73 CYP1A2 (0.60) CYP1A2CYP3A4CYP2C19CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654238-A1 2-AMINOPYRIMIDINE AND 2-AMINOPYRIDINE-4-CARBAMATES FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AMGEN INC. (US) 2006-05-10 EP disclosed
WO-2005009978-A1 2-AMINOPYRIMIDINE AND 2-AMINOPYRIDINE-4-CARBAMATES FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AMGEN INC. (US) 2005-02-03 WO disclosed